Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...

How could Trump’s tariffs affect prices, availability at the pharmacy? “That additional 10 percent tariff is going to have a ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo Nordisk's blockbuster diabetes and weight-loss drug Ozempic, Hypera's chief ...

"Our manufacturers sell at an extremely low price ... that shut down production lines. In some cases, drug manufacturers stopped making a drug. Because so many U.S. generic drug companies purchase ...

The ongoing conflicts between Ukraine and Russia, as well as Israel and Palestine, have sent ripples across various ...

In India, around 101 million people suffer from diabetes. More than half of these patients do not have their blood sugar ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces an ...

A generic product cannot enter the market until the originator product’s IP has expired, but the development process can take ...

UnitedHealth Group Inc.’s drug-benefits unit is starting to reimburse pharmacies more for dispensing brand-name medicines to ...

There comes a point in the life of every brand when exclusivity will be lost and generics will begin to compete for market share. However this is not the end of the brand’s lifecycle and many ...